Page last updated: 2024-08-17

medroxyprogesterone acetate and Cancer, Second Primary

medroxyprogesterone acetate has been researched along with Cancer, Second Primary in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hensiek, AE; Hill, JT; Kellerman, AJ1

Other Studies

2 other study(ies) available for medroxyprogesterone acetate and Cancer, Second Primary

ArticleYear
Estrogen replacement therapy in women with previously treated breast cancer. ACOG Committee Opinion: Committee on Gynecologic Practice Number 135-April 1994.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 1994, Volume: 45, Issue:2

    Topics: Adult; Breast Neoplasms; Case-Control Studies; Delayed-Action Preparations; DNA, Neoplasm; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Norgestrel; Postmenopause; Risk Factors; RNA, Neoplasm; Tamoxifen

1994
Spontaneous regression of a solitary cerebral metastases in renal carcinoma followed by meningioma development under medroxyprogesterone acetate therapy.
    British journal of neurosurgery, 2000, Volume: 14, Issue:4

    Topics: Adult; Antineoplastic Agents, Hormonal; Brain Neoplasms; Carcinoma, Renal Cell; Follow-Up Studies; Humans; Kidney Neoplasms; Male; Medroxyprogesterone Acetate; Meningioma; Neoplasm Regression, Spontaneous; Neoplasms, Second Primary

2000